Ikhofi Eliluhlaza

-Delile

• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

Ubhontshisi "wekhofi eluhlaza" yimbewu yekhofi (ubhontshisi) wezithelo zekhofi ezingakatholwa. Inqubo yokuwosa inciphisa inani lekhemikhali elibizwa nge-chlorogenic acid. Ngakho-ke, ubhontshisi wekhofi oluhlaza unezinga eliphakeme le-chlorogenic acid uma kuqhathaniswa nobhontshisi ojwayelekile, othosiwe wekhofi. I-Chlorogenic acid ekhofi eluhlaza kucatshangwa ukuthi inezinzuzo zezempilo.

Ikhofi eliluhlaza lathandwa kakhulu lokwehlisa isisindo ngemuva kokuba kukhulunywe ngalo embukisweni kaDkt Oz ngo-2012. Umbukiso kaDkt Oz wawubiza ngokuthi "Ubhontshisi wekhofi oluhlaza oshisa amanoni ngokushesha" futhi uthi akukho ukuzivocavoca noma ukudla okudingekayo.

Abantu bathatha ikhofi eluhlaza okokukhuluphala, isifo sikashukela, umfutho wegazi ophakeme, nezinye izimo, kepha abukho ubufakazi obuhle besayensi obusekela okuningi kwalokhu kusetshenziswa.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze IKHOFU ELILUHLAZA zimi kanje:

Ubufakazi obanele bokukala ukusebenza kwe ...

• Umfutho wegazi ophezulu. Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha ikhofi eluhlaza okotshani kuze kube amasonto ayi-12 ngokuthobekile kunciphisa umfutho wegazi kubantu abadala abane-high high blood pressure.
• Ukuqoqwa kwezimpawu ezandisa ubungozi besifo sikashukela, isifo senhliziyo, nesifo sohlangothi (isifo se-metabolic syndrome). Ucwaningo lwangaphambilini luphakamisa ukuthi ukuthatha ikhofi eluhlaza kukhipha umfutho wegazi noshukela wegazi ngesamba esincane kubantu abadala abanalesi simo. Kepha ushukela wegazi namazinga we-cholesterol namanye amafutha awazange athuthukiswe.
• Ukukhuluphala ngokweqile. Ukuthatha ikhofi eluhlaza okotshani amasonto ayi-8-12 kubonakala kunciphisa isisindo ngenani elincane kakhulu kubantu abadala abakhuluphele noma kubantu abadala abanokukhuluphala.
• I-cholesterol ephezulu.
• Isifo i-Alzheimer.
• Isifo sikashukela.
• Ezinye izimo.

Kudingeka ubufakazi obengeziwe ukukala ikhofi eluhlaza ngalokhu kusetshenziswa.

Ubhontshisi wekhofi oluhlaza ubhontshisi wekhofi ongakatholwa. Lezi zibhontshisi zekhofi ziqukethe inani eliphakeme le-chlorogenic acid yamakhemikhali. Leli khemikhali kucatshangwa ukuthi linezinzuzo zezempilo. Ngomfutho wegazi ophakeme kungathinta imithambo yegazi ukuze kwehle umfutho wegazi.

Ukwehlisa isisindo, i-chlorogenic acid ekhofi eluhlaza kucatshangwa ukuthi ithinta indlela umzimba ophatha ngayo ushukela wegazi kanye ne-metabolism.

Lapho ithathwa ngomlomo: Ikhofi eliluhlaza ngu OKUNGENZEKA UKUPHEPHA lapho ithathwa ngokufanele. Ukukhishwa kwekhofi eluhlaza okwenziwe ngemithamo kuze kufike ku-480 mg nsuku zonke kusetshenziswe ngokuphepha kuze kube amasonto ayi-12. Futhi, ikhofi ethile eluhlaza (iSvetol, i-Naturex) isetshenziswe ngokuphepha ngemithamo efinyelela kuma-200 mg kahlanu ngosuku nsuku zonke kuze kube amasonto ayi-12.

Ikhofi eluhlaza iqukethe i-caffeine. Kuncafine encane kakhulu ekhofi eluhlaza kunekhofi ejwayelekile. Kodwa ikhofi eluhlaza isengadala imiphumela emibi ehlobene ne-caffeine efana nekhofi. Lokhu kufaka phakathi ukuqwasha, ukwethuka nokungazinzi, ukucasuka esiswini, isicanucanu nokuhlanza, ukukhuphuka kwenhliziyo nokuphefumula, neminye imiphumela emibi. Ukuphuza inani elikhulu lekhofi nakho kungadala ikhanda, ukukhathazeka, ukukhathazeka, ukukhala ezindlebeni, nokushaya kwenhliziyo okungajwayelekile.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Alukho ulwazi olwanele oluthembekile lokwazi ukuthi ngabe ikhofi eluhlaza iphephile ukusetshenziswa uma ukhulelwe noma uncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Amazinga aphakeme ngokungajwayelekile we-homocysteine: Ukusebenzisa umthamo ophakeme we-chlorogenic acid isikhathi esifushane kubangele ukwanda kwamazinga e-plasma homocysteine, angahle ahambisane nezimo ezinjengesifo senhliziyo.

Izinkinga zokukhathazeka: I-caffeine esekhofi eluhlaza ingenza ukukhathazeka kube kubi kakhulu.

Izinkinga zokopha: Kukhona ukukhathazeka okuthile ngokuthi i-caffeine esekhofi eluhlaza ingenza ukuphazamiseka kokopha kube kubi kakhulu.

Isifo sikashukela: Olunye ucwaningo lubonisa ukuthi i-caffeine equkethwe ikhofi eluhlaza ingashintsha indlela abantu abanesifo sikashukela abenza ngayo ushukela. ICaffeine kubikwe ukuthi idala ukwanda kanye nokwehla kukashukela egazini. Sebenzisa i-caffeine ngokuqapha uma unesifo sikashukela futhi ubheke ushukela wegazi ngokucophelela.

Uhudo: Ikhofi eliluhlaza line-caffeine. I-caffeine esekhofi, ikakhulukazi uma iphuzwa kakhulu, ingalwenza lube muncu uhudo.

Isifo sokuwa: Ikhofi eluhlaza iqukethe i-caffeine. Abantu abanesithuthwane kufanele bagweme ukusebenzisa i-caffeine ngemithamo ephezulu. Imithamo ephansi ye-caffeine kufanele isetshenziswe ngokuqapha.

I-Glaucoma: Ukuthatha i-caffeine equkethwe ikhofi eluhlaza kungakhuphula ingcindezi ngaphakathi kweso. Ukwanda kuqala kungakapheli imizuzu engama-30 futhi kuhlala okungenani imizuzu engama-90.

Umfutho wegazi ophezulu: Ukuthatha i-caffeine etholakala kukhofi eluhlaza kungakhuphula umfutho wegazi kubantu abane-high blood pressure. Kodwa-ke, lo mphumela ungahle ube mncane kubantu abadla i-caffeine kusuka kukhofi eluhlaza noma eminye imithombo njalo.

I-irritable bowel syndrome (IBS): Ikhofi eluhlaza iqukethe i-caffeine. I-caffeine esekhofi eluhlaza, ikakhulukazi uma ithathwa kakhulu, ingase ibe sibi kakhulu isifo sohudo abanye abantu abanaso nge-IBS.

Ukuncipha kwamathambo (ukukhumuzeka kwamathambo): I-caffeine evela kukhofi eluhlaza neminye imithombo ingakhuphula inani le-calcium ekhishwe emchameni. Lokhu kunganciphisa amathambo. Uma une-osteoporosis, nciphisa ukusetshenziswa kwe-caffeine ibe ngaphansi kuka-300 mg ngosuku. Ukuthatha izithasiselo ze-calcium kungasiza ekwenzeni i-calcium elahlekile. Uma uvame ukuba nempilo enhle futhi uthola i-calcium eyanele ekudleni kwakho noma kwizithasiselo, ukuthatha u-400 mg we-caffeine nsuku zonke (cishe izinkomishi ezingama-20 zekhofi eluhlaza) akubonakali kwandisa ingozi yokuthola i-osteoporosis. Abesifazane be-Postmenopausal abanesimo esizuzwe njengefa esibenza bangaqhubeki nokwenza uvithamini D ngokujwayelekile, kufanele baqaphele ikakhulukazi lapho besebenzisa i-caffeine.

Maphakathi

Qaphela ngale nhlanganisela.

I-Adenosine (Adenocard)

I-caffeine esekhofi eluhlaza ingavimba imiphumela ye-adenosine (Adenocard). I-Adenosine (i-Adenocard) ivame ukusetshenziswa odokotela ukwenza ukuhlolwa enhliziyweni. Lokhu kuhlolwa kubizwa ngokuthi yi-cardiac test test. Yeka ukusebenzisa ikhofi eluhlaza noma eminye imikhiqizo equkethe i-caffeine okungenani amahora angama-24 ngaphambi kokuhlolwa kwengcindezi yenhliziyo.

Utshwala (i-Ethanol)

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. Utshwala bunganciphisa ukuthi umzimba wephula ngokushesha kangakanani i-caffeine. Ukuthatha ikhofi eluhlaza kanye notshwala kungahle kudale i-caffeine eningi egazini nasemiphumeleni emibi ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu nokushaya kwenhliziyo okusheshayo.

I-Alendronate (Fosamax)

Ikhofi eluhlaza ingahle inciphise ukuthi i-alendronate (Fosamax) engakanani yomzimba oyithathayo. Ukuthatha ikhofi eluhlaza kanye ne-alendronate (Fosamax) ngasikhathi sinye kunganciphisa ukusebenza kwe-alendronate (Fosamax). Ungathathi ikhofi eluhlaza kungakapheli amahora amabili uthathe i-alendronate (Fosamax).

I-Clozapine (Clozaril)

Umzimba wephula i-clozapine (i-Clozaril) ukuze uyiqede. I-caffeine esekhofi eluhlaza ingahle yehlise ukuthi umzimba wehla ngokushesha kanjani i-clozapine (Clozaril). Ukuthatha ikhofi eluhlaza kanye ne-clozapine (Clozaril) kungakhuphula imiphumela kanye nemiphumela emibi ye-clozapine (Clozaril).

I-Dipyridamole (Persantine)

I-caffeine esekhofi eluhlaza ingavimba imiphumela ye-dipyridamole (Persantine). IDipyridamole (Persantine) ivame ukusetshenziswa odokotela ukwenza ukuhlolwa enhliziyweni. Lokhu kuhlolwa kubizwa ngokuthi yi-cardiac test test. Yeka ukuthatha ikhofi eluhlaza noma eminye imikhiqizo equkethe i-caffeine okungenani amahora angama-24 ngaphambi kokuhlolwa kwengcindezi yenhliziyo.

I-Disulfiram (Antabuse)

Umzimba uphula i-caffeine esekhofi eluhlaza ukuze uyiqede. I-Disulfiram (Antabuse) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha okukhulu. Ukuthatha ikhofi eluhlaza kanye ne-disulfiram (i-Antabuse) kungakhuphula imiphumela kanye nemiphumela emibi yekhofi eluhlaza kufaka phakathi i-jitteriness, hyperactivity, irritability, nabanye.

Ephedrine

Izidakamizwa ezikhuthazayo zisheshisa isimiso sezinzwa. I-caffeine esekhofi eluhlaza kanye ne-ephedrine yizidakamizwa ezivuselelayo. Ukuthatha ikhofi eliluhlaza kanye ne-ephedrine kungadala ukukhuthazeka kakhulu futhi kwesinye isikhathi kube nemiphumela emibi kakhulu nezinkinga zenhliziyo. Ungathathi imikhiqizo equkethe i-caffeine kanye ne-ephedrine ngasikhathi sinye.

Ama-Estrogens

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. Ama-Estrogens anganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukuphuza amaphilisi e-estrogen nekhofi eluhlaza kungadala ukuqina, ikhanda, ukushaya kwenhliziyo okusheshayo, neminye imiphumela emibi.Uma uthatha amaphilisi e-estrogen nciphisa isilinganiso sakho sokudla okune-caffeine.

Amanye amaphilisi e-estrogen afaka phakathi ama-equine estrogens ahlanganisiwe (Premarin), i-ethinyl estradiol, i-estradiol namanye.

I-Fluvoxamine (Luvox)

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. I-Fluvoxamine (Luvox) inganciphisa ukuthi umzimba uyiphula masinyane kanjani i-caffeine. Ukuthatha i-caffeine kanye ne-fluvoxamine (i-Luvox) kungadala i-caffeine eningi emzimbeni, futhi kwandise imiphumela kanye nemiphumela emibi ye-caffeine.

ILithium

Umzimba wakho ngokwemvelo ususa i-lithium. I-caffeine esekhofi eluhlaza ingakhuphula ukuthi umzimba wakho ususa i-lithium ngokushesha kangakanani. Uma uthatha imikhiqizo equkethe i-caffeine futhi uphuza i-lithium, yeka ukuthatha imikhiqizo ye-caffeine kancane. Ukuyeka i-caffeine ngokushesha kungakhuphula imiphumela emibi ye-lithium.

Imithi ye-asthma (i-Beta-adrenergic agonists)

Ikhofi eluhlaza iqukethe i-caffeine. I-caffeine ingashukumisa inhliziyo. Eminye imishanguzo ye-asthma nayo ingashukumisa inhliziyo. Ukuthatha i-caffeine ngemithi ethile ye-asthma kungadala ukukhuthazeka kakhulu futhi kubangele izinkinga zenhliziyo.

Eminye imithi yesifo somoya ihlanganisa i-albuterol (i-Proventil, i-Ventolin, i-Volmax), i-metaproterenol (i-Alupent), i-terbutaline (i-Bricanyl, i-Brethine) ne-isoproterenol (i-Isuprel).

Imithi yokudangala (MAOIs)

I-caffeine esekhofi eluhlaza ingavuselela umzimba. Eminye imishanguzo esetshenziselwa ukucindezeleka nayo ingakhuthaza umzimba. Ukuthatha ikhofi eluhlaza nokuphuza imishanguzo yokudangala kungadala ukukhuthazeka kakhulu kanye nemiphumela emibi ebandakanya ukushaya kwenhliziyo okusheshayo, umfutho wegazi ophakeme, uvalo nokunye.

Eminye yale mithi esetshenziselwa ukucindezeleka ifaka phakathi i-phenelzine (Nardil), i-tranylcypromine (i-Parnate), neminye.

Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)

I-caffeine esekhofi eluhlaza ingahle inciphise ukujiya kwegazi. Ukuthatha ikhofi eluhlaza kanye nemithi futhi ejija kancane ukuvimba kungandisa amathuba okulinyazwa nokopha.

Eminye imishanguzo eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-diclofenac (i-Voltaren, i-Cataflam, abanye), i-ibuprofen (i-Advil, i-Motrin, abanye), i-naproxen (i-Anaprox, i-Naprosyn, abanye), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox) , heparin, warfarin (Coumadin), nabanye.

I-Nicotine

Ukuthatha i-caffeine ngekhofi eluhlaza kanye ne-nicotine kungakhuphula izinga lokushaya kwenhliziyo okusheshayo nomfutho wegazi.

I-Pentobarbital (Nembutal)

Imiphumela evuselelayo ye-caffeine esekhofi eluhlaza ingavimba imiphumela ekhiqiza ukulala ye-pentobarbital.

I-Phenylpropanolamine

I-caffeine esekhofi eluhlaza ingavuselela umzimba. I-Phenylpropanolamine nayo ingashukumisa umzimba. Ukuthatha i-caffeine ne-phenylpropanolamine ndawonye kungahle kukhuthaze kakhulu futhi kukhuphule ukushaya kwenhliziyo, umfutho wegazi, futhi kubangele ukwethuka.

Isi-Riluzole (Rilutek)

Umzimba wephula i-riluzole (Rilutek) ukuze uyiqede. Ukuthatha ikhofi eluhlaza kunganciphisa ukuthi umzimba wephula kanjani i-riluzole (Rilutek) ngokushesha okukhulu. Ngokwethiyori, ukusetshenziswa okuhlanganisiwe kungakhuphula imiphumela kanye nemiphumela emibi ye-riluzole.

Izidakamizwa ezikhuthazayo

Izidakamizwa ezikhuthazayo zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi isheshise ukushaya kwenhliziyo yakho. I-caffeine esekhofi eluhlaza nayo ingasheshisa uhlelo lwezinzwa. Ukuthatha ikhofi eluhlaza kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kubandakanya ukukhuphuka kwenhliziyo nomfutho wegazi ophezulu. Gwema ukuthatha izidakamizwa ezivuselelayo kanye nekhofi eluhlaza.

Eminye imishanguzo evuselelayo ifaka phakathi i-diethylpropion (Tenuate), i-epinephrine, i-phentermine (Ionamin), i-pseudoephedrine (i-Sudafed), neminye eminingi.

Theophylline

I-caffeine esekhofi eluhlaza isebenza ngokufana ne-theophylline. I-caffeine nayo inganciphisa ukuthi umzimba ususa kanjani i-theophylline ngokushesha okukhulu. Ukuthatha ikhofi eluhlaza nokuthatha i-theophylline kungakhuphula imiphumela kanye nemiphumela emibi ye-theophylline.

I-Verapamil (Calan, abanye)

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. IVerapamil inganciphisa ukuthi umzimba ususa kanjani ngokushesha i-caffeine. Ukuphuza ikhofi nokuthatha i-verapamil kungakhuphula ubungozi bemiphumela emibi yekhofi eluhlaza kufaka phakathi i-jitteriness, ikhanda elibuhlungu, nokushaya kwenhliziyo okwandisiwe.

Okuncane

Qaphela ngale nhlanganisela.

Ama-antibiotic (ama-antibiotic e-Quinolone)

Umzimba wephula i-caffeine ekhofi eluhlaza ukuze uyiqede. Eminye imishanguzo inganciphisa ukuthi umzimba uphula ngokushesha kanjani i-caffeine. Ukuthatha le mithi kanye nekhofi eluhlaza kungakhuphula ubungozi bemiphumela emibi kubandakanya i-jitteriness, ikhanda, ukukhuphuka kwenhliziyo, nokunye.

Amanye ama-antibiotic anciphisa ukuthi umzimba uphula kanjani ngokushesha i-caffeine afaka i-ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), namanye.

Amaphilisi okulawula inzalo (Izidakamizwa zokuvimbela inzalo)

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. Amaphilisi okulawula ukubeletha anganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukuthatha ikhofi eluhlaza kanye namaphilisi okulawula ukubeletha kungadala ukuqina, ikhanda, ukushaya kwenhliziyo okusheshayo, neminye imiphumela emibi.

Amanye amaphilisi okulawula ukubeletha afaka i-ethinyl estradiol ne-levonorgestrel (Triphasil), i-ethinyl estradiol ne-norethindrone (i-Ortho-Novum 1/35, i-Ortho-Novum 7/7/7), namanye.

I-Cimetidine (Tagamet)

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. I-Cimetidine (Tagamet) inganciphisa ukuthi umzimba wakho wephula ngokushesha kanjani i-caffeine. Ukuthatha i-cimetidine (Tagamet) kanye nekhofi eluhlaza kungakhuphula amathuba okuba nemiphumela engemihle ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu, ukushaya kwenhliziyo okusheshayo, nokunye.

I-Fluconazole (Diflucan)

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. I-Fluconazole (i-Diflucan) ingahle yehlise ukuthi umzimba ususa i-caffeine ngokushesha kangakanani. Ukuthatha i-fluconazole (i-Diflucan) nekhofi eluhlaza kungakhuphula imiphumela kanye nemiphumela emibi yekhofi kubandakanya ukwethuka, ukukhathazeka nokuqwasha.

Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)

I-caffeine esekhofi eluhlaza ingakhuphula ushukela wegazi. Imithi yesifo sikashukela isetshenziselwa ukwehlisa ushukela wegazi. Ngokwandisa ushukela wegazi, ikhofi eluhlaza inganciphisa ukusebenza kwemithi yesifo sikashukela. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.

Eminye imithi esetshenziselwa isifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .

Imithi yokwelapha umfutho wegazi ophakeme (Imithi efuthayo)

Ikhofi eluhlaza inganciphisa umfutho wegazi. Ukuthatha ikhofi eluhlaza kanye nemithi yomfutho wegazi ophezulu kungadala ukuthi umfutho wegazi lakho wehle kakhulu.

Eminye imishanguzo yomfutho wegazi ophakeme ifaka i-captopril (Capoten), i-enalapril (i-Vasotec), i-losartan (i-Cozaar), i-valsartan (i-Diovan), i-diltiazem (i-Cardizem), i-Amlodipine (i-Norvasc), i-hydrochlorothiazide (i-HydroDIURIL), i-furosemide (i-Lasix), neminye eminingi .

I-Mexiletine (Mexitil)

Ikhofi eluhlaza iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Mexiletine (Mexitil) inganciphisa ukuthi umzimba wephula ngokushesha kanjani i-caffeine. Ukuthatha iMexiletine (Mexitil) kanye nekhofi eluhlaza kungakhuphula imiphumela emibi ehlobene ne-caffeine yekhofi eluhlaza.

I-Terbinafine (Lamisil)

Umzimba uphula i-caffeine esekhofi eliluhlaza ukuze uyiqede. I-Terbinafine (i-Lamisil) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha futhi inyuse ubungozi bemiphumela emibi kubandakanya i-jitteriness, ikhanda elibuhlungu, ukushaya kwenhliziyo okwengeziwe, neminye imiphumela.

Okumunyu okusawolintshi

Umunyu owolintshi ngokuhlanganiswa ne-caffeine noma amakhambi aqukethe i-caffeine angakhuphula umfutho wegazi nokushaya kwenhliziyo kubantu abadala abaphilile abanomfutho wegazi ojwayelekile. Lokhu kungakhuphula ubungozi bokuba nezinkinga zenhliziyo ezinkulu. Gwema le nhlanganisela.

Amakhambi aqukethe i-caffeine nezithako

Ukusebenzisa ikhofi eluhlaza kanye namanye amakhambi aqukethe i-caffeine kanye nezengezo kwandisa ukuvezwa kwe-caffeine futhi kwandisa ingozi yokuthola imiphumela emibi ehlobene ne-caffeine. Eminye imithi yemvelo equkethe i-caffeine ifaka phakathi itiye elimnyama, ukhokho, i-cola nut, itiye eliluhlaza, itiye le-oolong, i-guarana, ne-mate.

I-calcium

Ukudla okuphezulu kwe-caffeine ekudleni naseziphuzweni okubandakanya ikhofi eluhlaza kukhulisa inani le-calcium ekhishwe emchameni.

Cyclodextrin

I-fiber cyclodextrin yokudla ikhonjiswe ukuthi iyinkimbinkimbi nezakhi ezithile zekhofi eluhlaza ezibhekele imiphumela yayo yokwehlisa umfutho wegazi. Ngokwethiyori, ukusebenzisa i-cyclodextrin nekhofi eluhlaza kunganciphisa ukumuncwa kwalesi sakhi futhi kunciphise imiphumela yaso ekucindezelweni kwegazi.

I-Ephedra (Ma huang)

Ikhofi eliluhlaza line-caffeine, evuselelayo. Ukusebenzisa ikhofi eluhlaza nge-ephedra, nayo evuselelayo, kungakhuphula ubungozi bokuthola imiphumela emibi noma esongela impilo efana nomfutho wegazi ophakeme, isifo senhliziyo, isifo sohlangothi, ukuquleka nokufa. Gwema ukuthatha ikhofi nge-ephedra nezinye izikhuthazi.

Amakhambi nezengezo ezinganciphisa umfutho wegazi

Ikhofi eliluhlaza linciphisa umfutho wegazi. Uma isetshenziswa namanye amakhambi nezengezo ezinciphisa umfutho wegazi, ikhofi eliluhlaza lingaba nemiphumela yokwehlisa umfutho wegazi. Eminye imithi yemvelo enemiphumela yokwehlisa umfutho wegazi ifaka i-alpha-linolenic acid, i-blond psyllium, i-calcium, i-cocoa, uwoyela we-cod, i-coenzyme Q-10, i-garlic, iminqumo, i-potassium, i-pycnogenol, i-orange elimnandi, i-vitamin C, i-bran bran, neminye .

Amakhambi nezithasiselo ezingehlisa ushukela egazini

Ukukhishwa kwekhofi eluhlaza kunganciphisa amazinga kashukela egazini. Ukuyisebenzisa namanye amakhambi noma izithasiselo ezinomphumela ofanayo kungadala ukuthi amazinga kashukela egazi ehle kakhulu. Amanye amakhambi nezengezo ezinganciphisa ushukela wegazi zifaka i-alpha-lipoic acid, i-chromium, i-devil's claw, i-fenugreek, i-garlic, i-guar gum, i-chestnut yamahhashi, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, nezinye.

Amakhambi nezengezo ezinganciphisa ukujiya kwegazi

I-caffeine esekhofi eluhlaza ingahle inciphise ukujiya kwegazi. Ukuthatha ikhofi eluhlaza nokusebenzisa amakhambi angahle anciphise nokuqina kwegazi kungakhuphula ingozi yokopha kwabanye abantu. Amanye ala makhambi afaka i-angelica, i-clove, i-danshen, i-garlic, i-ginger, i-ginkgo, i-Panax ginseng, namanye.

Insimbi

Izingxenye ezithile zekhofi eluhlaza zingavimbela i-iron ukuthi ingangeni ekudleni. Ngokwethiyori, lokhu kungaholela ekutheni amazinga wensimbi emzimbeni abe phansi kakhulu.

Magnesium

Ukuthatha inani elikhulu lekhofi eliluhlaza kungakhuphula inani le-magnesium elikhishwe emchameni.

I-Melatonin

Ukuthatha i-caffeine ne-melatonin ndawonye kungakhuphula amazinga e-melatonin.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo ofanele wekhofi eluhlaza uncike ezicini eziningana ezifana nobudala bomsebenzisi, impilo, nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi lokunquma ububanzi obufanele bemithamo yekhofi eluhlaza (ezinganeni / kubantu abadala). Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

I-Arabica Green Coffee Beans, Café Marchand, Café Verde, Café Vert, Coffea arabica, Coffea arnoldiana, Coffea bukobensis, Coffea canephora, Coffea liberica, Coffea robusta, Extrait de Café Vert, Extrait de Fève de Café Vé, Vele de Café Vert Arabica, Fèves de Café Vert Robusta, GCBE, GCE, Green Coffee Beans, Green Coffee Bean Extract, Green Coffee extract, Green Coffee Powder, Poudre de Café Vert, Raw Coffee, Raw Coffee Extract, Robusta Green Coffee Beans, Svetol .

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. URoshan H, Nikpayam O, Sedaghat M, Sohrab G. Imiphumela yekhofi eluhlaza ekhishwa ukwengezwa kuma-indices we-anthropometric, ukulawula kwe-glycemic, umfutho wegazi, iphrofayili ye-lipid, ukumelana ne-insulin kanye nesifiso seziguli ezine-metabolic syndrome: isilingo somtholampilo esingahleliwe. UBr J Nutriti. 2018; 119: 250-258. Buka okungaqondakali.
2. UChen H, uHuang W, uHuang X, et al. Imiphumela yokukhishwa kukabhontshisi obuluhlaza kumazinga wamaprotheni asebenzayo e-C: Ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kokuhlolwa okulawulwa ngokungahleliwe. Qedelela iTher Med. 2020; 52: 102498. Buka okungaqondakali.
3. I-Twaruzek M, i-Kosicki R, i-Kwiatkowska-Gizynska J, i-Grajewski J, i-Altyn I. I-Ochratoxin A ne-citrinin kukhofi eluhlaza kanye nezengezo zokudla ezikhishwe ikhofi eluhlaza. Ubuthi. 2020; 188: 172-177. Buka okungaqondakali.
4. UNikpayam O, Najafi M, Ghaffari S, Jafarabadi MA, Sohrab G, Roshanravan N. Imiphumela yokukhishwa kwekhofi eluhlaza ekuzileni ukudla kwegazi, ukugxila kwe-insulin kanye nokuhlolwa kwemodeli ye-homeostatic yokumelana ne-insulin (HOMA-IR): ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta yezifundo zokungenelela. I-Diabetol Metab Syndr. 2019; 11: 91. Buka okungaqondakali.
5. UMartínez-López S, uSarriá B, uMateos R, uBravo-Clemente L. Ukusetshenziswa okulinganiselwe kwekhofi eluhlaza / eyosiwe encibilikile ene-caffeoylquinic acid kunciphisa izimpawu zengozi yenhliziyo: imiphumela evela ekuhlolweni okungahleliwe, okuwela, okulawulwayo ezifundweni ezinempilo neze-hypercholesterolemic . Eur J Umsoco. 2019; 58: 865-878. Buka okungaqondakali.
6. UAsbaghi ​​O, uSadeghian M, uRahmani S, et al. Umphumela wokusengezelwa kwekhofi eluhlaza okotshani kwizinyathelo ze-anthropometric kubantu abadala: Ukubuyekezwa okuhlelekile okuhlelekile nokuhlaziywa kwemethamo yokuphendula imethamo yokuhlolwa okungahleliwe kwemitholampilo. Qedelela iTher Med. 2020; 51: 102424. Buka okungaqondakali.
7. I-Cozma-Petrut A, i-Loghin F, i-Miere D, i-Dumitrascu DL. Ukudla nge-irritable bowel syndrome: Yini ongayincoma, hhayi okufanele ukwenqabela iziguli! Umhlaba J Gastroenterol. 2017; 23: 3771-3783. Buka okungaqondakali.
8. I-Rao SS. Izinketho zokwelashwa zamanje nezisavelayo zokungabambezeli kwe-fecal. UJ Clin Gastroenterol. 2014; 48: 752-64. Buka okungaqondakali.
9. U-Wikoff D, i-Welsh BT, uHenderson R, et al. Ukubuyekezwa okuhlelekile kwemiphumela emibi engaba khona yokusetshenziswa kwe-caffeine kubantu abadala abanempilo, abesifazane abakhulelwe, intsha kanye nezingane. Ukudla Chem Toxicol 2017; 109: 585-648. Buka okungaqondakali.
10. UCappelletti S, uPiacentino D, uFineschi V, uFrati P, uCipollini L, u-Aromatario M. Ukufa okuhlobene ne-Caffeine: indlela yokufa kanye nezigaba zengozi. Izakhamzimba. 2018 uMeyi 14; 10. pii: E611. Buka okungaqondakali.
11. UMagdalan J, uZawadzki M, uSkowronek R, et al. Ukudakwa okungapheli nokuzala nge-caffeine emsulwa - umbiko wamacala amathathu ahlukene. I-Forensic Sci Med Pathol. 2017 Septhemba; 13: 355-58. Buka okungaqondakali.
12. UTejani FH, Thompson RC, Kristy R, Bukofzer S. Umphumela we-caffeine ku-SPECT myocardial perfusion imaging ngesikhathi se-regadenoson pharmacologic stress: isifundo esingahle senzeke, esingahleliwe, se-multicenter. I-Int J Cardiovasc Ukucabanga. 2014 Juni; 30: 979-89. i-doi: 10.1007 / s10554-014-0419-7. I-Epub 2014 17. Buka okungaqondakali.
13. UPoussel M, Kimmoun A, Levy B, Gambier N, Dudek F, Puskarczyk E, Poussel JF, Chenuel B. Fatal cardiac arrhythmia elandela ukweqisa kwe-caffeine ngokweqile kumdlali we-amateur owakha umzimba. I-Int J Cardiol. 2013 1; 166: e41-2. i-doi: 10.1016 / j.ijcard.2013.01.238. I-Epub 2013 7. Akukho okungajwayelekile okutholakalayo. Buka okungaqondakali.
14. UJabbar SB, uHanly MG. Ukudlula ngokweqile kwe-caffeine: umbiko wecala nokubuyekezwa kwezincwadi. Ngingu-J J Forensic Med Pathol. 2013; 34: 321-4. i-doi: 10.1097 / PAF.0000000000000058. Buyekeza. Buka okungaqondakali.
15. IBonsignore A, Sblano S, Pozzi F, Ventura F, Dell'Erba A, Palmiere C. Icala lokuzibulala ngokungenisa i-caffeine. I-Forensic Sci Med Pathol. 2014 Septhemba; 10: 448-51. i-doi: 10.1007 / s12024-014-9571-6. I-Epub 2014 27. Buka okungaqondakali.
16. Beaudoin MS, Allen B, Mazzetti G, Sullivan PJ, Graham TE. Ukungeniswa kwe-caffeine kuphazamisa ukuzwela kwe-insulin ngendlela encike kumthamo kwabesilisa nabesifazane. I-Appl Physiol Nutrap Metab. 2013; 38: 140-7. i-doi: 10.1139 / apnm-2012-0201. I-Epub 2012 9. Buka okungaqondakali.
17. Iphakethe Lokwaziswa Lomkhiqizo weSvetol. INaturex, Avignon, eFrance. Mashi 2013. Kutholakala ku: http://greencoffee.gr/wp-content/uploads/2013/12/GA501071_PRODUCT-INFO-PACK_04-06-2013.pdf (kufinyelelwe ngoJulayi 6, 2015).
18. UVinson J, uBurnham B. Ukuhlehliswa: Ukulawulwa okungahleliwe, okuyimpumputhe, okulawulwa yi-placebo, umthamo oqondile, isifundo se-crossover ukuhlola ukusebenza nokuphepha kokukhishwa kukabhontshisi oluhlaza okotshani ezifundweni ezikhuluphele kakhulu. Isifo Sikashukela Metab Syndr Obes 2014; 7: 467. Kutholakala ku: www.ncbi.nlm.nih.gov/pmc/articles/PMC4206203/.
19. Ukukhishwa Kwezindaba ZaseFederal Trade Commission. Umkhiqizi kabhontshisi wekhofi oluhlaza ukhokhela amacala e-FTC okuphusha umkhiqizo wawo ngokuya ngemiphumela yocwaningo "lokwehluleka kakhulu" lokwehlisa isisindo. Kutholakala ku: www.ftc.gov/news-events/press-releases/2014/09/green-coffee-bean-manufacturer-settles-ftc-charges-pushing-its (kufinyelelwe ngoJulayi 5, 2015).
20. I-Saito, T., Tsuchida, T., Watanabe, T., Arai, Y., Mitsui, Y., Okawa, W., neKajihara, Y. Umphumela webhontshisi yekhofi ukhishwe ku-hypertension ebalulekile. IJpn J Med Pharm Sci 2002; 47: 67-74.
21. UBlum, J., Lemaire, B., noLafay, S. Umphumela wokukhishwa okuluhlaza okotshani okwenziwe nge-decaffeinated ku-glycaemia: isifundo somshayeli esingaba khona. I-Nutrafoods 2007; 6: 13-17.
22. UDellalibera, O., Lemaire, B., noLafay, S. Svetol®, ukukhishwa kwekhofi eluhlaza, kubangela ukwehla kwesisindo futhi kukhuphule isilinganiso sokuncipha kwamafutha kumavolontiya anenkinga yokukhuluphala. I-Phytotherapie 2006; 4: 1-4.
23. I-Arion, WJ, Canfield, WK, Ramos, FC, Schindler, PW, Burger, HJ, Hemmerle, H., Schubert, G., Ngezansi, P., noHerling, i-AW Chlorogenic acid kanye ne-hydroxynitrobenzaldehyde: izivimbela ezintsha ze-glucose hepatic 6 -phosphatase. I-Arch.I-Biochemys.I-Biophys. 3-15-1997; 339: 315-322. Buka okungaqondakali.
24. Peyresblanques, J. [Ukungezwani komzimba nokuhlangana kwekhofi eluhlaza]. Inkunzi.Soc.Ophtalmol.Fr. 1984; 84: 1097-1098. Buka okungaqondakali.
25. UFranzke, C., Grunert, K. S., Hildebrandt, U., noGriehl, H. [Kokuqukethwe kwe-theobromine ne-theophylline yekhofi eluhlaza netiyi]. I-Pharmazie 9-9-1968; 23: 502-503. Buka okungaqondakali.
26. UZuskin, E., Kanceljak, B., Skuric, Z., noButkovic, D. Ukuvuselelwa kwebronchial ekuvezweni kwekhofi eluhlaza. Br.J.Ind.Med. 1985; 42: 415-420. Buka okungaqondakali.
27. Uragoda, C. G. Izimpawu ezinzima kubasebenzi bekhofi. J.Trop.I-Med.Hyg. 1988; 91: 169-172. Buka okungaqondakali.
28. USuzuki, A., Fujii, A., Jokura, H., Tokimitsu, I., Hase, T., noSaito, I. I-Hydroxyhydroquinone iphazamisa ukubuyiselwa kwe-chlorogenic acid okubangelwa ukusebenza kwe-endothelial ngamagundane ane-hypertensive. Am. J. Hypertens. 2008; 21: 23-27. Buka okungaqondakali.
29. USelmar, D., Bytof, G., noKnopp, S. E. Ukugcinwa kwekhofi eluhlaza (i-Coffea arabica): ukwehla kokusebenza kanye nezinguquko zabangeneleli bephunga abangahle babe khona. U-Ann. 2008; 101: 31-38. Buka okungaqondakali.
30. U-Oka K. Yakugaku Zasshi 2007; 127: 1825-1836. Buka okungaqondakali.
31. UTakahama, U., Ryu, K., noHirota, S.I-Chlorogenic acid ekhofi ingavimbela ukwakheka kwe-dinitrogen trioxide ngokudlalisa i-nitrogen dioxide ekhiqizwe emgodini womlomo womuntu. J.Agric. Ukudla Chem. 10-31-2007; 55: 9251-9258. Buka okungaqondakali.
32. I-Monteiro, M., Farah, A., Perrone, D., Trugo, L. C., noDonangelo, C. Amakhemikhali e-Chlorogenic acid avela ekhofi afakwa ngokuhlukile futhi ahlanganiswe nabantu. UJ. Nutr. 2007; 137: 2196-2201. Buka okungaqondakali.
33. UGlei, M., Kirmse, A., Habermann, N., Persin, C., noPool-Zobel, B. L. Isinkwa esithuthukiswe ngokukhishwa kwekhofi eluhlaza sinemisebenzi ye-chemoprotective ne-antigenotoxic kumaseli womuntu. Umsoco. Umdlavuza 2006; 56: 182-192. Buka okungaqondakali.
34. UGreenberg, J. A., Boozer, C.N, noGeliebter, A. Ikhofi, isifo sikashukela nokulawulwa kwesisindo. NginguJ. J.Clin. Nutr. 2006; 84: 682-693. Buka okungaqondakali.
35. USuzuki, A., Fujii, A., Yamamoto, N., Yamamoto, M., Ohminami, H., Kameyama, A., Shibuya, Y., Nishizawa, Y., Tokimitsu, I., noSaito, I. Ukwenza ngcono umfutho wegazi ophakeme kanye nokungasebenzi kwemithambo yegazi ngekhofi elingenayo i-hydroxyhydroquinone kwimodeli yofuzo yomfutho wegazi ophezulu. FEBS Lett. 4-17-2006; 580: 2317-2322. Buka okungaqondakali.
36. UHigdon, J. V. noFrei, B. Ikhofi nezempilo: ukubuyekezwa kocwaningo lwakamuva lwabantu. Crit Rev. Ukudla Sci. 2006; 46: 101-123. Buka okungaqondakali.
37. UGlauser, T., Bircher, A., noWuthrich, B. [I-allergen rhinoconjunctivitis ebangelwa uthuli lukabhontshisi wekhofi oluhlaza]. I-Schweiz.Med.Wochenschr. 8-29-1992; 122: 1279-1281. Buka okungaqondakali.
38. UGonthier, M. P., Verny, M. A., Besson, C., Remesy, C., noScalbert, A. I-Chlorogenic acid bioavailability incike kakhulu ekuguqulweni komzimba yi-gut microflora kumagundane. UJ. Nutr. 2003; 133: 1853-1859. Buka okungaqondakali.
39. U-Olthof, M. R., Hollman, P. C., Buijsman, M. N., van Amelsvoort, J. M., noKatan, M. B. Chlorogenic acid, quercetin-3-rutinoside kanye nama-black tea phenols ahlanganiswe kakhulu kubantu. UJ. Nutr. 2003; 133: 1806-1814. Buka okungaqondakali.
40. UMoridani, M. Y., Scobie, H., no-O'Brien, P. J. Metabolism we-caffeic acid ngamagundane e-hepatocyte ahlukanisiwe kanye nezingxenyana ezingaphansi kwamaseli. Ubuthi. 7-21-2002; 133 (2-3): 141-151. Buka okungaqondakali.
41. UDaglia, M., Tarsi, R., Papetti, A., Grisoli, P., Dacarro, C., Pruzzo, C., noGazzani, G. Umphumela we-Antiadhesive wekhofi eliluhlaza futhi eligazingiwe ezintweni zokunamathela zeStreptococcus mutans ubuhlalu be-hydroxyapatite obugqokiwe. J.Agric. Ukudla Chem. 2-27-2002; 50: 1225-1229. Buka okungaqondakali.
42. URichelle, M., Tavazzi, I., no-Offord, E. Ukuqhathaniswa komsebenzi we-antioxidant weziphuzo ezivame ukusetshenziswa ze-polyphenolic (ikhofi, ukhokho netiye) okulungiselelwe inkomishi ngayinye ekhonzayo. J.Agric. Ukudla Chem. 2001; 49: 3438-3442. Buka okungaqondakali.
43. UCouteau, D., McCartney, A. L., Gibson, G. R., Williamson, G., noFaulds, C. B. Ukuhlukaniswa nokuhlukaniswa kwamagciwane e-colonic womuntu akwazi ukwenza i-hydrolyse chlorogenic acid. IMicrobiol. 2001; 90: 873-881. Buka okungaqondakali.
44. UDaglia, M., Papetti, A., Gregotti, C., Berte, F., noGazzani, G. In vitro antioxidant kanye ne-ex vivo imisebenzi yokuvikela ikhofi eluhlaza kanye eyosiwe. J.Agric. Ukudla Chem. 2000; 48: 1449-1454. Buka okungaqondakali.
45. UHerling, A. W., Burger, H., Schubert, G., Hemmerle, H., Schaefer, H., noKramer, W. Ukuguqulwa kwe-carbohydrate kanye ne-lipid intermediary metabolism ngesikhathi sokuvimbela i-glucose-6-phosphatase kumagundane. I-Eur. J. Pharmacol. 12-10-1999; 386: 75-82. Buka okungaqondakali.
46. IBassoli, BK, Cassolla, P., Borba-Murad, GR, Constantin, J., Salgueiro-Pagadigorria, CL, Bazotte, RB, da Silva, RS, no-Souza, i-HM Chlorogenic acid inciphisa i-plasma glucose peak ngomlomo ukuhlolwa kokubekezelelana kwe-glucose: imiphumela ekukhishweni kwe-glucose hepatic kanye ne-glycaemia. Iseli Biochem. 2008; 26: 320-328. Buka okungaqondakali.
47. U-Almeida, A. A., Farah, A., Silva, D. A., Nunan, E. A., noGloria, M. B. Umsebenzi wokulwa namagciwane wezinto zekhofi kanye nezinhlanganisela zamakhemikhali zekhofi ezikhethiwe ngokumelene ne-enterobacteria. J Agric. Ukudla Chem 11-15-2006; 54: 8738-8743. Buka okungaqondakali.
48. UDimaio, V. J. noGarriott, J. C. Lethal ubuthi be-caffeine enganeni. I-Forensic Sci. Ngo-1974; 3: 275-278. Buka okungaqondakali.
49. U-Alstott, R. L., Miller, A. J., noForney, R. B. Umbiko wokufa komuntu ngenxa ye-caffeine. Isayensi Yezomnotho. Ngo-1973; 18: 135-137. Buka okungaqondakali.
50. Orozco-Gregorio, H., Mota-Rojas, D., Bonilla-Jaime, H., Trujillo-Ortega, ME, Becerril-Herrera, M., Hernandez-Gonzalez, R., noVillanueva-Garcia, D. Imiphumela ye ukuphathwa kwe-caffeine kokuguquguqukayo kwemethodi ezingulubeni ezisanda kuzalwa ezine-peripartum asphyxia. NginguJ. J Vet. 2010; 71: 1214-1219. Buka okungaqondakali.
51. I-Thelander, G., Jonsson, A. K., Personne, M., Forsberg, G. S., Lundqvist, K. M., no-Ahlner, J. Caffeine ukufa - ingabe imikhawulo yokuthengisa ivimbela ukudakwa ngamabomu? I-Clin Toxicol. (Phila) 2010; 48: 354-358. Buka okungaqondakali.
52. UBuscemi, S., Verga, S., Batsis, JA, Donatelli, M., Tranchina, MR, Belmonte, S., Mattina, A., Re, A., noCerasola, G. Imiphumela emibi yekhofi ekusebenzeni kwe-endothelial ezifundweni ezinempilo. Eur.J Umsoco Wasemtholampilo. 2010; 64: 483-489. Buka okungaqondakali.
53. URudolph, T. noKnudsen, K. Icala lobuthi obubulala i-caffeine. I-Acta Anaesthesiol.Scand 2010; 54: 521-523. Buka okungaqondakali.
54. UMoisey, uL. L., uRobinson, uL., NoGraham, u-T. Ukusetshenziswa kwekhofi ene-caffeine kanye nesidlo se-carbohydrate ephezulu kuthinta umzimba we-postprandial wokuhlolwa kokubekezelelana kwe-glucose ngomlomo kwabesilisa abancane, abanempilo. Br. J Umsoco. 2010; 103: 833-841. Buka okungaqondakali.
55. IMacKenzie, T., Comi, R., Sluss, P., Keisari, R., Manwar, S., Kim, J., Larson, R., noBaron, JA Imiphumela ye-Metabolic ne-hormonal ye-caffeine: okungahleliwe, okuphindwe kabili- isilingo se-crossover esilawulwa nge-placebo. I-Metabolism 2007; 56: 1694-1698. Buka okungaqondakali.
56. van Dam, R. M. Ikhofi nohlobo 2 sikashukela: kusuka kubhontshisi kuya kuma-beta-cell. Umsoco weMetab Cardiovasc. 2006; 16: 69-77. Buka okungaqondakali.
57. USmits, P., Temme, L., noTeen, T. Ukusebenzisana kwenhliziyo phakathi kwe-caffeine ne-nicotine ebantwini. I-Clin Pharmacol Ther 1993; 54: 194-204. Buka okungaqondakali.
58. U-Liu, T. T. no-Liau, J. Caffeine kwandisa ukulingana kwempendulo ebonakalayo ye-BOLD. I-Neuroimage. 2-1-2010; 49: 2311-2317. Buka okungaqondakali.
59. Ursing, C., Wikner, J., Brismar, K., noRojdmark, S. Caffeine iphakamisa izinga le-serum melatonin ezifundweni ezinempilo: inkomba ye-melatonin metabolism yi-cytochrome P450 (CYP) 1A2. UJ. Endocrinol. Ukutshalwa kwezimali ngo-2003; 26: 403-406. Buka okungaqondakali.
60. UHartter, S., Nordmark, A., Rose, D. M., Bertilsson, L., Tybring, G., noLaine, K. Imiphumela yokudla kwe-caffeine ku-pharmacokinetics ye-melatonin, umuthi wokuhlola umsebenzi we-CYP1A2. Br.J.Clin.Pharmacol. 2003; 56: 679-682. Buka okungaqondakali.
61. UGasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., noCzuczwar, uSJ Felbamate ukhombisa ukuthambekela okuphansi kokusebenzisana ne-methylxanthines kanye ne-Ca2 + modulators yesiteshi ekulweni nokuquleka kokuhlola kumagundane. . I-Eur. J Pharmacol 7-10-1998; 352 (2-3): 207-214. Buka okungaqondakali.
62. UVaz, J., Kulkarni, C., David, J., noJoseph, T. Umthelela we-caffeine kuphrofayli ye-pharmacokinetic ye-sodium valproate ne-carbamazepine kumavolontiya avamile abantu. Indian J.Exp.Ibhayisikili. 1998; 36: 112-114. Buka okungaqondakali.
63. UChroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., noCzuczwar, S. J. Caffeine kanye ne-anticonvulsant potency yezidakamizwa ze-antiepileptic: idatha yokuhlola neyomtholampilo. IPharmacol. 2011; 63: 12-18. Buka okungaqondakali.
64. ILuszczki, J. J., Zuchora, M., Sawicka, K. M., Kozinska, J., noCzuczwar, S. J. Ukuvezwa kahle kwe-caffeine kunciphisa isenzo se-anticonvulsant se-ethosuximide, kepha hhayi i-clonazepam, i-phenobarbital ne-valproate ekulweni nokuhlaselwa okubangelwa yi-pentetrazole kumagundane. I-Pharmacol Rep. 2006; 58: 652-659. Buka okungaqondakali.
65. UJankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., noCzuczwar, S. J. [I-caffeine nemithi yokulwa nesifo sokuwa: idatha yokuhlola neyomtholampilo]. I-Przegl.Lek. 2007; 64: 965-967. Buka okungaqondakali.
66. UGasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., noCzuczwar, S. J. Umsebenzi we-Anticonvulsant we-phenobarbital ne-valproate yokulwa ne-electroshock enkulu kumagundane ngesikhathi sokwelapha okungapheli nge-caffeine ne-caffeine yokuyeka. Isifo sokuwa 1996; 37: 262-268. Buka okungaqondakali.
67. UFuhr, U., Strobl, G., Manaut, F., Anders, EM, Sorgel, F., Lopez-de-Brinas, E., Chu, DT, Pernet, AG, Mahr, G., Sanz, F. , futhi. Ama-Quinolone antibacterial agents: ubudlelwane phakathi kwesakhiwo kanye ne-in vitro inhibition ye-cytochrome yomuntu i-P450 isoform CYP1A2. UMol. Pharmacol. 1993; 43: 191-199. Buka okungaqondakali.
68. UStille, W., Harder, S., Mieke, S., Beer, C., Shah, P. M., Frech, K., noStaib, A. H. Ukwehla kokuqedwa kwe-caffeine kumuntu ngesikhathi sokubusa ngokubambisana kwama-4-quinolones. J. Antimicrob. Umama. 1987; 20: 729-734. Buka okungaqondakali.
69. UStaib, A.H, Stille, W., Dietlein, G., Shah, P. M., Harder, S., Mieke, S., noBhiya, C. Ukusebenzisana phakathi kwama-quinolones ne-caffeine. Izidakamizwa 1987; 34 Suppl 1: 170-174. Buka okungaqondakali.
70. IKynast-Gales SA, iMassey LK. Umphumela we-caffeine ekukhishweni kwe-circadian ye-urinary calcium ne-magnesium. J Am Coll Umsoco. 1994; 13: 467-72. Buka okungaqondakali.
71. Irwin PL, King G, Hicks KB. I-Polymerized cyclomaltoheptaose (i-beta-cyclodextrin, i-beta-CDn) ukufaka ukwakheka okuyinkimbinkimbi ne-chlorogenic acid: imiphumela ye-solvent ku-thermochemistry kanye ne-enthalpy-entropy compensation. I-Carbohydr Res. 1996 Feb 28; 282: 65-79. Buka okungaqondakali.
72. I-Irwin PL, iPfeffer PE, iDoner LW, et al. Ukubopha i-geometry, i-stoichiometry, ne-thermodynamics ye-cyclomalto-oligosaccharide (cyclodextrin) ukufaka ukwakheka okuyinkimbinkimbi ne-chlorogenic acid, i-substrate enkulu ye-apple polyphenol oxidase. I-Carbohydr Res. 1994 Mar 18; 256: 13-27. Buka okungaqondakali.
73. UMoreira DP, uMonteiro MC, uRibeiro-Alves M, et al. Umnikelo wama-chlorogenic acid emsebenzini wokunciphisa insimbi weziphuzo zekhofi. J Agric Ukudla Chem. 2005 uMar 9; 53: 1399-402. Buka okungaqondakali.
74. IHurrell RF, uReddy M, uCook JD. Ukuvimbela ukumuncwa kwensimbi okungeyona i-haem kumuntu ngeziphuzo eziqukethe i-polyphenolic. UBr J Nutr 1999; 81: 289-95. Buka okungaqondakali.
75. van Rooij J, van der Stegen GH, Schoemaker RC, et al. Ucwaningo olufanayo olulawulwa yi-placebo ngomphumela wezinhlobo ezimbili zamafutha ekhofi kuma-serum lipids nakuma-transaminases: ukuhlonza izinto zamakhemikhali ezibandakanyeka kumphumela wokukhulisa ikhofi nge-cholesterol. Ngingu-J J Nutriti Womtholampilo. 1995 Juni; 61: 1277-83. Buka okungaqondakali.
76. - UJackson, uL. S. noLee, K. Izinhlobo zamakhemikhali zensimbi, i-calcium, i-magnesium ne-zinc kukhofi nakudla lamagundane aqukethe ikhofi. I-J-Food-Prot. I-Ames, Iowa: Inhlangano Yomhlaba Wonke Yobisi, Ukudla, kanye Nama-Sanitarians Wezemvelo 1988; 51: 883-886.
77. IPereira MA, iParker ED, neFolsom AR. Ukusetshenziswa kwekhofi kanye nobungozi bohlobo 2 sikashukela mellitus: isifundo seminyaka engu-11 sabesifazane abayi-28 812 besifazane abasesimeni sokuya esikhathini. I-Arch Intern Med. 2006 Juni 26; 166: 1311-6. Buka okungaqondakali.
78. UJohnston KL, uClifford MN, uMorgan LM. Ikhofi iguqula kahle uketshezi lwama-gastrointestinal secretion kanye nokubekezelelana kwe-glucose kubantu: imiphumela ye-glycemic ye-chlorogenic acid ne-caffeine. Ngingu-J J Nutriti Womtholampilo. 2003 Okthoba; 78: 728-33. Buka okungaqondakali.
79. I-Keijzers GB, iDe Galan BE, iTack CJ, et al. I-caffeine inganciphisa ukuzwela kwe-insulin kubantu. Ukunakekelwa yisifo sikashukela. 2002 Febhuwari; 25: 364-9. Buka okungaqondakali.
80. UGreer F, uHudson R, uRoss R, et al. Ukungeniswa kwe-caffeine kunciphisa ukulahlwa kwe-glucose ngesikhathi se-hyperinsulinemic-euglycemic clamp kubantu abahlala phansi. Isifo sikashukela. 2001 Okthoba; 50: 2349-54. Buka okungaqondakali.
81. UThong FS noGraham TE. Ukukhubazeka okubangelwa yi-caffeine yokubekezelelana kwe-glucose kuqedwa yi-beta-adrenergic receptor blockade kubantu. J Appl Umzimba womzimba. 2002 Juni; 92: 2347-52. Buka okungaqondakali.
82. USuzuki A, uKagawa D, u-Ochiai R, et al. Ukukhishwa kukabhontshisi ohlaza okotshani kanye nama-metabolite ayo anomthelela we-hypotensive kumagundane ane-hypertensive. Ama-Hypertens Res. 2002 uJan; 25: 99-107. Buka okungaqondakali.
83. UBlum J, uLemaire B, noLafay S. Umphumela wokukhishwa kwekhofi eluhlaza okwenziwe nge-decaffeinated ku-glycaemia: isifundo somshayeli esingaba khona. I-Nutrafoods 2007; 6: 13-17.
84. UYamaguchi T, Chikama A, Mori K, et al. Ikhofi elingena-Hydroxyhydroquinone-free: blind-blind, randomized control-response response of khatello yegazi. I-Nutrab Metab Cardiovasc Dis. 2008 Julayi; 18: 408-14. Buka okungaqondakali.
85. U-Olthol MR, uHollman PCH, uKatan MB. I-Chlorogenic acid ne-caffeic acid ziyangena ebantwini. J Umsoco 2001; 131: 66-71. Buka okungaqondakali.
86. UVinson JA, uBurnham BR, uNagendran MV. Ukulawulwa okungahleliwe, okuyimpumputhe, okulawulwa yi-placebo, umthamo olinganiselwe, isifundo se-crossover ukuhlola ukusebenza nokuphepha kokukhishwa kwebhontshisi oluhlaza okotshani ezifundweni ezikhuluphele kakhulu. Isifo Sikashukela Metab Syndr Obes 2012; 5: 21-7. Buka okungaqondakali.
87. UDellalibera O, uLemaire B, uLafay S. Svetol, ukhishwa ikhofi oluhlaza, unciphisa ukwehla kwesisindo futhi akhuphule isilinganiso sokuncipha kwamafutha kumavolontiya anenkinga yokukhuluphala. I-Phytotherapie 2006; 4: 194-7.
88. Thom E. Umphumela we-chlorogenic acid ucebise ikhofi ekumunweni kwe-glucose kumavolontiya anempilo nomphumela wawo kubukhulu bomzimba lapho usetshenziswa isikhathi eside kubantu abakhuluphele nabakhuluphele. J Int Med Res 2007; 35: 900-8. Buka okungaqondakali.
89. U-Onakpoya I, uTerry R, ​​u-Ernst E. Ukusetshenziswa kokukhishwa kwekhofi eluhlaza njengesengezo sokulahlekelwa isisindo: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kokuhlolwa komtholampilo okungahleliwe. IGastroenterol Res Pract 2011; 2011. pii: 382852. Epub 2010 Aug 31. Buka okungaqondakali.
90. I-Alonso-Salces RM, Serra F, Reniero F, Héberger K. Botanical kanye nokwakheka kwendawo yekhofi eluhlaza (I-Coffea arabica neCoffea canephora): ukuhlolwa kwamakhemikhali kokuqukethwe kwe-phenolic ne-methylxanthine. J Agric Ukudla Chem 2009; 57: 4224-35. Buka okungaqondakali.
91. UShimoda H, Seki E, Aitani M. Umphumela wokuvimbela ukukhishwa kukabhontshisi obuluhlaza ekuqongeleleni amafutha kanye nokuzuza kwesisindo somzimba kumagundane. I-BMC Complement Altern Med 2006; 6: 9. Buka okungaqondakali.
92. UFarah A, uDonangelo CM. Ama-phenolic compounds ekhofi. I-Braz J Plant Physiol 2006; 18: 23-36.
93. UFarah A, uMonteiro M, uDonangelo CM, uLafay S. Ama-asidi e-Chlorogenic avela kukhishwe ikhofi eluhlaza atholakala kakhulu kubantu. J Okunomsoco 2008; 138: 2309-15. Buka okungaqondakali.
94. UWatanabe T, u-Arai Y, uMitsui Y, et al. Umphumela wokwehlisa umfutho wegazi nokuphepha kwe-chlorogenic acid kusuka kukabhontshisi wekhofi oluhlaza okukhishwe ku-hypertension ebalulekile. Umtholampilo Exp Hypertens 2006; 28: 439-49. Buka okungaqondakali.
95. UKozuma K, uTsuchiya S, uKohori J, et al. Umphumela we-antihypertensive we-green coffee bean ekhishwe ezifundweni ezinomfutho wegazi ophakeme. Ama-Hypertens Res. 2005 Septhemba; 28: 711-8. Buka okungaqondakali.
96. U-Ochiai R, uJokura H, uSuzuki A, et al. Ukukhishwa kukabhontshisi okuluhlaza okuluhlaza kuthuthukisa ukungasebenzi kahle komuntu. IHypertens Res 2004; 27: 731-7. Buka okungaqondakali.
97. UDuncan L. Ubhontshisi wekhofi oluhlaza oshisa amanoni ngokushesha. UDkt Oz Show, Ephreli 25, 2012. Itholakala ku: http://www.doctoroz.com/blog/lindsey-duncan-nd-cn/green-coffee-bean-burns-fat-fast.
98. ILake CR, iRosenberg DB, iGallant S, et al. I-Phenylpropanolamine inyusa amazinga e-plasma caffeine. I-Clin Pharmacol Ther 1990; 47: 675-85. Buka okungaqondakali.
99. I-Forrest WH Jr, iBellville JW, uBrown BW Jr. Ukusebenzisana kwe-caffeine ne-pentobarbital njenge-hypnotic yasebusuku. I-Anesthesiology 1972; 36: 37-41. Buka okungaqondakali.
100. URaaska K, uRaitasuo V, uLaitila J, uNeuvonen PJ. Imiphumela yekhofi equkethe i-caffeine uma iqhathaniswa ne-decaffeinated on concentrations ye-serum clozapine ezigulini ezibhedlela. I-Basic Clin Pharmacol Toxicol 2004; 94: 13-8. Buka okungaqondakali.
101. UWatson JM, uSherwin RS, uDeary IJ, et al. Ukuhlukaniswa kwempendulo engathandwayo yomzimba, yehomoni nokuqonda kwi-hypoglycaemia ngokusetshenziswa okuqhubekayo kwe-caffeine. I-Clin Sci (Lond) 2003; 104: 447-54. Buka okungaqondakali.
102. I-Winkelmayer WC, iStampfer MJ, iWillett WC, iCurhan GC. Ukudla okuvamile kwe-caffeine kanye nengozi yomfutho wegazi ophezulu kwabesifazane. I-JAMA 2005; 294: 2330-5. Buka okungaqondakali.
103. UJuliano LM, uGriffiths RR. Ukubuyekezwa okubucayi kokuhoxiswa kwe-caffeine: ukuqinisekiswa kwezimpawu nezimpawu, izehlakalo, ubunzima, nezici ezihambisanayo. I-Psychopharmacology (Berl) 2004; 176: 1-29. Buka okungaqondakali.
104. U-Anderson BJ, uGunn TR, uHolford NH, uJohnson R. Caffeine ukweqisa usana ngaphambi kwesikhathi: izifundo zomtholampilo kanye ne-pharmacokinetics. Ukunakekelwa Okujulile kwe-Anaesth 1999; 27: 307-11. Buka okungaqondakali.
105. ULeson CL, McGuigan MA, uBryson SM. Ukudlula ngokweqile kwe-caffeine kowesilisa osemusha. UJ Toxicol Clin Toxicol 1988; 26: 407-15. Buka okungaqondakali.
106. UBenowitz NL, u-Osterloh J, uGoldschlager N, et al. Ukukhishwa okukhulu kwe-catecholamine kusuka kubuthi be-caffeine. I-JAMA 1982; 248: 1097-8. Buka okungaqondakali.
107. IHallerle CA, uBenowitz NL, uJacob P 3rd. Imiphumela ye-Hemodynamic ye-ephedra-free weight-supplements supplements kubantu. U-Am J Med 2005; 118: 998-1003 .. Buka okungaqondakali.
108. UPetrie HJ, Chown SE, uBelfie LM, et al. Ukungeniswa kwe-caffeine kwandisa impendulo ye-insulin ekuhlolweni kokubekezela ngomlomo noshukela emadodeni akhuluphele ngaphambi nangemva kokulahleka kwesisindo. Ngingu-J J Nutriti 2004; 80: 22-8. Buka okungaqondakali.
109. ILane JD, iBarkauskas CE, iSurwit RS, iFeinglos MN. I-caffeine iphazamisa i-glucose metabolism kuhlobo 2 lwesifo sikashukela. Ukunakekelwa yisifo sikashukela 2004; 27: 2047-8. Buka okungaqondakali.
110. I-Durrant KL. Imithombo eyaziwayo nefihliwe ye-caffeine kwizidakamizwa, ekudleni nasemikhiqizweni yemvelo. UJ Am Pharm Assoc 2002; 42: 625-37. Buka okungaqondakali.
111. Ibhishi CA, iMays DC, iGuiler RC, et al. Ukuvimbela ukuqedwa kwe-caffeine yi-disulfiram ezifundweni ezijwayelekile nokubuyisa utshwala. I-Clin Pharmacol Ther 1986; 39: 265-70. Buka okungaqondakali.
112. UDews PB, O'Brien CP, uBergman J. Caffeine: imiphumela yokuziphatha yokuhoxa nezinkinga ezihlobene. Ukudla Chem Toxicol 2002; 40: 1257-61. Buka okungaqondakali.
113. UHolmgren P, uNorden-Pettersson L, u-Ahlner J. Caffeine oshonile - imibiko yamacala amane. I-Forensic Sci Int 2004; 139: 71-3. Buka okungaqondakali.
114. Isikhungo Sezokwelapha. I-Caffeine Yokusimamiswa Kokusebenza Komsebenzi Wengqondo: Amafomula Wokusebenza Kwezempi. Washington, DC: National Academy Press, 2001. Itholakala ku: http://books.nap.edu/books/0309082587/html/index.html.
115. UZheng XM, uWilliam RC. Amazinga e-serum caffeine ngemuva kokungavunyelwe kwamahora angama-24: imiphumela yomtholampilo ekucabangeni kwe-dipyridamole Tl myocardial perfusion. UJ Nucl Med Technol 2002; 30: 123-7. Buka okungaqondakali.
116. U-Aqel RA, uZoghbi GJ, uTrimm JR, et al. Imiphumela ye-caffeine efakwa ngemithambo yegazi ku-intracoronary-ephethwe i-adenosine-indone coronary hemodynamics ezigulini ezinesifo semithambo yegazi. NginguJ J Cardiol 2004; 93: 343-6. Buka okungaqondakali.
117. Underwood i-DA. Imiphi imishanguzo okufanele ibanjwe ngaphambi kokuhlolwa kwe-pharmacologic noma kokuvivinya umzimba? ICleve Clin J Med 2002; 69: 449-50. Buka okungaqondakali.
118. USmith A. Imiphumela ye-caffeine ekuziphatheni komuntu. Ukudla Chem Toxicol 2002; 40: 1243-55. Buka okungaqondakali.
119. UStanek EJ, uMelko GP, uCharland SL. Ukuphazamiseka kweXanthine ne-dipyridamole-thallium-201 imaging myocardial. Ikhemisi 1995; 29: 425-7. Buka okungaqondakali.
120. UCarrillo JA, uBenitez J.Ukuxhumana okuphawulekayo kwemithi phakathi kokudla okune-caffeine nemithi. Umtholampilo Pharmacokinet 2000; 39: 127-53. Buka okungaqondakali.
121. I-Wahllander A, i-Paumgartner G. Umphumela we-ketoconazole ne-terbinafine kuma-pharmacokinetics we-caffeine kumavolontiya anempilo. I-Eur J Clin Pharmacol 1989; 37: 279-83. Buka okungaqondakali.
122. USanderink GJ, uBournique B, uStevens J, et al.Ukubandakanywa kwama-isoenzymes we-CYP1A womuntu ekuxhumaneni kwe-metabolism kanye nezidakamizwa ze-riluzole in vitro. I-Pharmacol Exp Ther 1997; 282: 1465-72. Buka okungaqondakali.
123. UBrown NJ, uRyder D, uGatsha RA. Ukusebenzisana kwe-pharmacodynamic phakathi kwe-caffeine ne-phenylpropanolamine. I-Clin Pharmacol Ther 1991; 50: 363-71. Buka okungaqondakali.
124. U-Abernethy DR, Todd EL. Ukukhubazeka kokuvunyelwa kwe-caffeine ngokusetshenziswa okungapheli kwezindlela zokuvimbela inzalo zomlomo ezinomthamo ophansi. I-Eur J Clin Pharmacol 1985; 28: 425-8. Buka okungaqondakali.
125. UMay DC, uJarboe CH, uVanBakel AB, uWilliam WM. Imiphumela ye-cimetidine esimweni se-caffeine kubantu ababhemayo nabangabhemi. I-Clin Pharmacol Ther 1982; 31: 656-61. Buka okungaqondakali.
126. UGertz BJ, Holland SD, Kline WF, et al. Izifundo zokutholakala komlomo kwe-alendronate. I-Clin Pharmacol Ther 1995; 58: 288-98. Buka okungaqondakali.
127. UNawrot P, Jordan S, Eastwood J, et al. Imiphumela ye-caffeine empilweni yomuntu. I-Addit Contam yokudla 2003; 20: 1-30. Buka okungaqondakali.
128. UMassey LK, uWhiting SJ. I-caffeine, i-calcium yomchamo, i-calcium metabolism kanye nethambo. UJ Nutriti 1993; 123: 1611-4. Buka okungaqondakali.
129. I-Infante S, iBaeza ML, iCalvo M, et al. I-Anaphylaxis ngenxa ye-caffeine. Ukungezwani komzimba 2003; 58: 681-2. Buka okungaqondakali.
130. UNix D, uZelenitsky S, uSymonds W, et al. Umphumela we-fluconazole kuma-pharmacokinetics we-caffeine ezifundweni ezincane nezindala. I-Clin Pharmacol Ther 1992; 51: 183.
131. UKockler DR, uMcCarthy MW, uLawson CL. Umsebenzi wokubamba nokungaphenduli ngemuva kokungeniswa kwe-hydroxycut. I-Pharmacotherapy 2001; 21: 647-51 .. Buka okungaqondakali.
132. IMassey LK. Ingabe i-caffeine iyingozi ekulahlekelweni kwethambo kubantu asebekhulile? Ngingu-J J Clin Nutr 2001; 74: 569-70. Buka okungaqondakali.
133. IBara AI, iBarley EA. I-caffeine yesifuba somoya. ICochrane Database Syst Rev 2001; 4: CD001112 .. Buka okungaqondakali.
134. UHorner NK, uLampe JW. Izindlela ezingaba khona zokwelashwa kokudla kwezimo zesifuba se-fibrocystic zibonisa ubufakazi obanele bokusebenza. J Am Diet Assoc 2000; 100: 1368-80. Buka okungaqondakali.
135. UBell DG, uJacobs I, u-Ellerington K. Umphumela we-caffeine ne-ephedrine ukungenisa ekusebenzeni kokuzivocavoca kwe-anaerobic. IMed Sci Sports Exerc 2001; 33: 1399-403. Buka okungaqondakali.
136. I-Avisar R, i-Avisar E, i-Weinberger D. Umphumela wokusetshenziswa kwekhofi ekucindezelekeni kwe-intraocular. I-Ann Pharmacother 2002; 36: 992-5 .. Buka okungaqondakali.
137. UFerrini RL, uBarrett-Connor E.Ukudla kwe-Caffeine namazinga we-sexo angapheli kwabesifazane be-postmenopausal. Isifundo seRancho Bernardo. Ngingu-J Epidemiol 1996: 144: 642-4. Buka okungaqondakali.
138. U-Olthof MR, uHollman PC, uZock PL, uKatan MB. Ukusetshenziswa kwemithamo ephezulu ye-chlorogenic acid, ekhona ekhofi, noma yetiye elimnyama kwandisa inani le-plasma inani le-homocysteine ​​ebantwini. Ngingu-J J Clin Nutr 2001; 73: 532-8. Buka okungaqondakali.
139. UKlag MJ, uWang NY, uMeoni LA, et al. Ukudla kwekhofi kanye nobungozi be-hypertension: Ucwaningo lwangaphambi kukaJohn Hopkins. I-Arch Intern Med 2002; 162: 657-62. Buka okungaqondakali.
140. I-Samarrae WA, iTruswell AS. Umphumela wesikhashana wesikhofi ekusebenzeni kwegazi le-fibrinolytic kubantu abadala abaphilile. I-Atherosclerosis 1977; 26: 255-60. Buka okungaqondakali.
141. U-Ardlie NG, uGlew G, uSchultz BG, uSchwartz CJ. Ukuvimbela nokubuyisa ukuhlanganiswa kweplatelet ngama-methyl xanthines. UTromb Diath Haemorrh 1967; 18: 670-3. Buka okungaqondakali.
142. U-Ali M, u-Afzal M. I-inhibitor enamandla ye-thrombin evuselele ukwakheka kweplatelet thromboxane kusuka etiyeni elingasetshenziswanga. AmaProstaglandins Leukot Med 1987; 27: 9-13. Buka okungaqondakali.
143. IHallerle CA, uBenowitz NL. Imicimbi emibi yenhliziyo nemithambo yegazi ehambisana nezithako zokudla eziqukethe i-ephedra alkaloids. N Engl J Med 2000; 343: 1833-8. Buka okungaqondakali.
144. USinclair CJ, uGiiger JD. Ukusetshenziswa kwe-caffeine kwezemidlalo. Ukubuyekezwa kwemithi. J Ezemidlalo Med Fitness 2000; 40: 71-9. Buka okungaqondakali.
145. ULloyd T, uJohnson-Rollings N, u-Eggli DF, et al. Isimo samathambo phakathi kwabesifazane be-postmenopausal abanokudla okuhlukile kwe-caffeine: uphenyo olude. UJ Am Coll Nutriti 2000; 19: 256-61. Buka okungaqondakali.
146. UWatson JM, uJenkins EJ, uHamilton P, et al. Ithonya le-caffeine kumvamisa nasekuboneni kwe-hypoglycemia ezigulini eziphila mahhala ezinesifo sikashukela sohlobo 1. Ukunakekelwa yisifo sikashukela 2000; 23: 455-9. Buka okungaqondakali.
147. UHagg S, Spigset O, Mjorndal T, Dahlqvist R. Umphumela we-caffeine kuma-pharmacokinetics e-clozapine kumavolontiya anempilo. UBr J Clin Pharmacol 2000; 49: 59-63. Buka okungaqondakali.
148. UBoozer CN, uNasser JA, uHeymsfield SB, et al. Isengezo semithi esineMa Huang-Guarana yokwehlisa isisindo: isilingo esingahleliwe, esiyimpumputhe. I-Int J Obes Relat Metab Disord 2001; 25: 316-24. Buka okungaqondakali.
149. UDews PB, uC Curtis GL, uHanford KJ, u-O'Brien CP. Ukuvama kokuhoxa kwe-caffeine kunhlolovo esekwe kubantu nasekuhlolweni okulawulwayo, okuyimpumputhe. UJ Clin Pharmacol 1999; 39: 1221-32. Buka okungaqondakali.
150. UNurminen ML, Niittynen L, Korpela R, Vapaatalo H. Ikhofi, i-caffeine nomfutho wegazi: ukubuyekeza okubucayi. I-Eur J Clin Nutr 1999; 53: 831-9. Buka okungaqondakali.
151. UPollock BG, uWylie M, uStack JA, et al. Ukuvinjelwa kwe-caffeine metabolism nge-estrogen therapy esikhundleni sabesifazane be-postmenopausal. UJ Clin Pharmacol 1999; 39: 936-40. Buka okungaqondakali.
152. URapuri PB, uGallagher JC, uKinyamu HK, uRyschon KL. Ukudla kwe-caffeine kukhuphula izinga lokulahleka kwamathambo kwabesifazane asebekhulile futhi kuhlangana ne-vitamin D receptor genotypes. Ngingu-J J Clin Nutr 2001; 74: 694-700. Buka okungaqondakali.
153. I-Chiu KM. Ukusebenza kwe-calcium supplements ku-bone mass kwabesifazane be-postmenopausal. UJ Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Buka okungaqondakali.
154. Ukuchazwa Kwezilingo Zokuxilonga. Amazwibela weLaboratory Medicine. Okwesihlanu ed; IBoston, MA: Little Brown, 1992.
155. UHodgson JM, uPuddey IB, uBurke V, et al. Imiphumela yengcindezi yegazi yokuphuza itiye eliluhlaza nokumnyama. UJ Hypertens 1999; 17: 457-63. Buka okungaqondakali.
156. Wakabayashi K, Kono S, Shinchi K, et al. Ukusetshenziswa kwekhofi ejwayelekile nokucindezelwa kwegazi: Ucwaningo lwezikhulu zokuzivikela eJapan. I-Eur J Epidemiol 1998; 14: 669-73. Buka okungaqondakali.
157. UVahedi K, uDomingo V, u-Amarenco P, uBousser MG. Ukushaywa yischemic kumuntu wezemidlalo odle okukhishwe uMaHuang futhi wakha i-monohydrate yokwakha umzimba. UJ Neurol Neurosurg Psychiatr 2000; 68: 112-3. Buka okungaqondakali.
158. UJoeres R, uKlinker H, uHeusler H, et al. Ithonya le-mexiletine ekususweni kwe-caffeine. I-Pharmacol Ther 1987; 33: 163-9. Buka okungaqondakali.
159. UJefferson JW. Ukuthuthumela kweLithium kanye nokudla kwe-caffeine: amacala amabili okuphuza kancane nokuthuthumela ngaphezulu. J Clin Psychiatry 1988; 49: 72-3. Buka okungaqondakali.
160. UMester R, uToren P, uMizrachi I, et al. Ukuhoxa kwe-caffeine kwandisa amazinga egazi e-lithium. I-Biol Psychiatry 1995; 37: 348-50. Buka okungaqondakali.
161. UHealy DP, uPolk RE, uKanawati L, et al. Ukusebenzisana phakathi komlomo we-ciprofloxacin ne-caffeine kumavolontiya ajwayelekile. Ama-Antimicrob Agents Chemother 1989; 33: 474-8. Buka okungaqondakali.
162. UCarbo M, uSegura J, uDe la Torre R, et al. Umphumela wama-quinolone esimweni se-caffeine. I-Clin Pharmacol Ther 1989; 45: 234-40. Buka okungaqondakali.
163. I-Harder S, i-Fuhr U, i-Staib AH, i-Wolff T. Ciprofloxacin-caffeine: ukuxhumana kwezidakamizwa okusungulwe kusetshenziswa uphenyo lwe-vivo kanye ne-in vitro. NginguJ Med 1989; 87: 89S-91S. Buka okungaqondakali.
164. UMcEvoy GK, umhleli. Imininingwane Yezidakamizwa ze-AHFS. I-Bethesda, MD: I-American Society of Health-System Pharmacists, ngo-1998.

Kugcine ukubuyekezwa - 03/01/2021